Key Insights

Highlights

Treatment Research

9 treatments under study, led by Magnetic Resonance Imaging

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07061977Phase 3RecruitingPrimary

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Showing all 1 trials

Research Network

Common Treatments

  • Magnetic Resonance Imaging1
  • Intensitymodulated Radiation Therapy1
  • Computed Tomography1
  • Paclitaxel1
  • Biospecimen Collection1

Active Sponsors

  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Stage Iiic2 Cervical Cancer Figo 20181
  • Stage Iva Cervical Cancer Figo 20181
  • Stage Iiia Cervical Cancer Figo 20181
  • Locally Advanced Cervical Adenosquamous Carcinoma1
  • Stage Iiib Cervical Cancer Figo 20181

Activity Timeline